Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
BioVaxys Technology Corp.
BVAXF
Primary Symbol:
C.BIOV
BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical...
-stage pipeline includes maveropepimut-S, which is in phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using its HapTenix neoantigen tumor cell construct platform for treating refractive late-stage ovarian cancer. The Company is also leveraging its expertise in tumor immunology by creating a unique library of T-lymphocytes and other datasets post-vaccination with its personalized immunotherapeutic vaccines to identify new targetable tumor antigens.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (CSE:BIOV)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
(12)
•••
cindfx1
X
View Profile
View Bullboard History
Comment by
cindfx1
on Jan 27, 2022 12:39pm
RE:On that note BIOV will start human tumour trials
Yes we are due for the clean room update along with a couple of other updates.
(23)
•••
terryow
X
View Profile
View Bullboard History
Post by
terryow
on Jan 27, 2022 10:20am
Asks .195 .20
0.20 2,500 1 0.195 4,500 2
QMET has 11 claims and 633 hectares Property in Ville-Marie, Quebec Hydrogen Camp
posted Nov 25, 2024 9:00am by
Q Precious & Battery Metals Corp.
-
|
The Company is pleased to discover that their Lorrain claims are now within the new and exciting exploration for hydrogen in the Ville-Marie, Lorrainville and Béarn region of Quebec. The region has undergone a claim staking rush following the ...read more
(115)
•••
Rossaporino
X
View Profile
View Bullboard History
Post by
Rossaporino
on Jan 26, 2022 10:40pm
Testing
https://www.telecinco.es/elprogramadeanarosa/secciones/sociedad/test-cutaneo-inmunidad-personas-metodo-validado-funciona_18_3272595391.html The skin test that determines how immune
...more
(115)
•••
Rossaporino
X
View Profile
View Bullboard History
Post by
Rossaporino
on Jan 26, 2022 9:25pm
Test
https://globalnews.ca/news/8538651/rapid-test-concerns-bc-covid19/
(23)
•••
terryow
X
View Profile
View Bullboard History
Post by
terryow
on Jan 26, 2022 3:05pm
Asks hiding behind .19 .20 .205 .21 .22
Ask 0.22 7,500 1 0.21 23,000 4 0.205 3,000 1 0.20 12,500 4
(328)
•••
moneywagon
X
View Profile
View Bullboard History
Post by
moneywagon
on Jan 26, 2022 2:46pm
BIOV SHORTS HAVE SP IN LOCKED BOX PRESSURE ASK UNDER @20
INFINITE....until Monday end of bi short session. Its a boring ho hum doji trading pattern until than. UNLESS a newswire comes and rocks our portfolio OR OR OR ...........Robinhood comes along
...more
(12)
•••
frankman
X
View Profile
View Bullboard History
Post by
frankman
on Jan 26, 2022 12:35pm
PAST news BioVaxys Cancer Vaccine Manufacturing Partner
VANCOUVER, British Columbia, Sept. 17, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys"), announced today that cancer vaccine
...more
(12)
•••
frankman
X
View Profile
View Bullboard History
Post by
frankman
on Jan 26, 2022 12:24pm
On that note BIOV will start human tumour trials
From biopsied samples from cancer patients. Tic toc.
(12)
•••
frankman
X
View Profile
View Bullboard History
Post by
frankman
on Jan 26, 2022 12:17pm
Covid and cancer are cured
Virus and disease are no longer a threat to us on earth. Once we get the other few billion earthlings vaccinated for the current virus. And cancer does not exist anymore. Tic toc.
(23)
•••
terryow
X
View Profile
View Bullboard History
Post by
terryow
on Jan 26, 2022 11:55am
Asks still .19 to .23 with up gaps
Ask 0.23 8,500 2 0.21 18,000 2 0.205 13,000 1 0.20 6,500 3 0.19
...more
(23)
•••
terryow
X
View Profile
View Bullboard History
Post by
terryow
on Jan 26, 2022 10:53am
Asks .19 to .23 with gap ups
Ask 0.23 8,500 2 0.21 18,000 2 0.205 13,000 1 0.20 6,500 3 0.19
...more
(10)
•••
Bomdrou999
X
View Profile
View Bullboard History
Comment by
Bomdrou999
on Jan 26, 2022 7:35am
RE:Biovaxys technology
The company is named at the end in this article. If BIOVAXYS develops this technology, expect a very rapid share price increase. https://mynmedia.mynews.es/document/:931133D/00001711-20220123-005130/
...more
(115)
•••
Rossaporino
X
View Profile
View Bullboard History
Post by
Rossaporino
on Jan 25, 2022 9:08pm
Biovaxys technology
https://mobile.twitter.com/ybpcph/status/1486028194021101577
(23)
•••
terryow
X
View Profile
View Bullboard History
Post by
terryow
on Jan 25, 2022 4:10pm
.19 Hope you got some
15:58:32 C 0.19
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Options Trading for Retiring: Key Strategies in Balancing Retirement Income
One Property, One Focus on Advancing this Gold Project in Ontario